Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Teleflex Incorporated (TFX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: TFX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -13.88% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.27B USD | Price to earnings Ratio 94.16 | 1Y Target Price 165.22 |
Price to earnings Ratio 94.16 | 1Y Target Price 165.22 | ||
Volume (30-day avg) 1631681 | Beta 1.21 | 52 Weeks Range 128.23 - 248.84 | Updated Date 04/1/2025 |
52 Weeks Range 128.23 - 248.84 | Updated Date 04/1/2025 | ||
Dividends yield (FY) 0.98% | Basic EPS (TTM) 1.49 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.29% | Operating Margin (TTM) 19.21% |
Management Effectiveness
Return on Assets (TTM) 3.7% | Return on Equity (TTM) 1.61% |
Valuation
Trailing PE 94.16 | Forward PE 10.04 | Enterprise Value 7733481687 | Price to Sales(TTM) 2.06 |
Enterprise Value 7733481687 | Price to Sales(TTM) 2.06 | ||
Enterprise Value to Revenue 2.54 | Enterprise Value to EBITDA 17.83 | Shares Outstanding 44680300 | Shares Floating 46220409 |
Shares Outstanding 44680300 | Shares Floating 46220409 | ||
Percent Insiders 0.3 | Percent Institutions 105.74 |
Analyst Ratings
Rating 3.36 | Target Price 238.68 | Buy 5 | Strong Buy - |
Buy 5 | Strong Buy - | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Teleflex Incorporated
Company Overview
History and Background
Teleflex Incorporated was founded in 1943. Initially focused on mechanical remote control systems, it evolved into a global provider of medical devices, driven by strategic acquisitions and organic growth.
Core Business Areas
- Vascular Solutions: Offers a range of vascular access and intervention devices, including catheters, guidewires, and drainage systems.
- Interventional Urology: Provides products for treating urological conditions, such as benign prostatic hyperplasia (BPH) and urinary incontinence.
- Surgical Solutions: Focuses on surgical instruments and devices, including ligation, clip appliers, and closure devices.
- Anesthesia and Respiratory: Offers products for airway management, respiratory care, and anesthesia delivery.
- OEM (Original Equipment Manufacturer): Provides custom-engineered solutions to other medical device manufacturers.
Leadership and Structure
Liam J. Kelly is the Chairman, President, and Chief Executive Officer. The organizational structure includes various business unit heads reporting to the CEO, with centralized functions for finance, legal, and human resources.
Top Products and Market Share
Key Offerings
- Arrow EZ-IO Intraosseous Vascular Access System: A device for establishing immediate vascular access in emergency situations. Competitors include Vidacare (Teleflex acquired) and PerSys Medical. Market share data is not readily available publicly, but EZ-IO is a market leader.
- Revenue:
- Revenue:
- UroLift System: A minimally invasive procedure for treating BPH. Competitors include Boston Scientific (GreenLight Laser), Olympus (Rezum), and Medtronic (InterStim). Teleflex has the highest market share in this segment.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulation, and increasing demand driven by an aging population and technological advancements.
Positioning
Teleflex is a diversified medical device company with a strong presence in vascular access, interventional urology, and surgical solutions. Competitive advantages include a broad product portfolio, established distribution channels, and a focus on innovation.
Total Addressable Market (TAM)
The global medical device market is estimated to be worth hundreds of billions of dollars. Teleflex is positioned to capture a portion of this TAM through its focus on specific therapeutic areas and product innovation. Expected market value is around $530 Billion (USD)
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Established distribution channels
- Strong brand reputation
- Focus on innovation
- History of strategic acquisitions
Weaknesses
- Dependence on acquisitions for growth
- Exposure to regulatory risks
- Integration challenges with acquired companies
- Susceptible to recalls
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Addressing unmet clinical needs
Threats
- Increasing competition
- Price pressures from healthcare providers
- Changing regulatory landscape
- Product liability claims
Competitors and Market Share
Key Competitors
- BSX
- MDT
- JNJ
Competitive Landscape
Teleflex competes with a variety of medical device companies, including larger, more diversified players and smaller, more specialized companies. Teleflex differentiates itself through its focus on specific therapeutic areas and its broad product portfolio.
Major Acquisitions
Standard Bariatrics, Inc.
- Year: 2022
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded its surgical solutions portfolio into the bariatric surgery market. Enhances offerings and market position in surgical weight loss procedures.
Growth Trajectory and Initiatives
Historical Growth: Teleflex has grown through a combination of organic growth and acquisitions. Organic growth has been driven by new product launches and market penetration.
Future Projections: Analysts project continued growth for Teleflex, driven by demand for its products and expansion into new markets.
Recent Initiatives: Recent initiatives include the launch of new products, expansion into emerging markets, and strategic acquisitions.
Summary
Teleflex is a reasonably strong, diversified medical device company that is growing through strategic acquisitions and organic expansion. It is well-positioned in growing markets, has an overall positive financial performance, and good shareholder returns. However, they should carefully manage integration risks associated with acquisitions and be aware of regulatory requirements of the Medical Device industry.
Similar Companies
ABT
Abbott Laboratories
ABT
Abbott Laboratories
BDX
Becton Dickinson and Company
BDX
Becton Dickinson and Company
BSX
Boston Scientific Corp
BSX
Boston Scientific Corp
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SYK
Stryker Corporation
SYK
Stryker Corporation
Sources and Disclaimers
Data Sources:
- Teleflex Investor Relations
- SEC Filings
- Analyst Reports
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is based on available estimates and may not be precise. Financial data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teleflex Incorporated
Exchange NYSE | Headquaters Wayne, PA, United States | ||
IPO Launch date 1988-02-18 | Chairman, President & CEO Mr. Liam J. Kelly | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 14100 | Website https://www.teleflex.com |
Full time employees 14100 | Website https://www.teleflex.com | ||
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.